Rain Oncology Inc.

8-K

Completion of Acquisition or Disposition of Assets, Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Material Modification to Rights of Security Holders, Change of Control, Change in Directors, Officers or Compensation, Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

01/26/24

8-K

Other Events

01/19/24

8-K

Enters Into Agreement to Be Acquired by Pathos AI for $1.16 in Cash Per Share Plus Contingent Value Rights

12/14/23

8-K

Reports Third Quarter 2023 Financial Results and Provides Business Update

11/09/23

8-K

Reports Second Quarter 2023 Financial Results and Provides Corporate Update

08/10/23

8-K

######## ####### ###### ### ######## ######### ########## ## ########### ######## ########

06/05/23

8-K

######### ####### ####### #### ##### # ###### ##### ## ########### ### ### ######### ## ################ ###########

05/22/23

Search in Documents

Key Exhibits

External Links

Financials Filter

Prospectuses and Registrations Filter

Ownership Filter

News Filter

Proxies Filter

Other Filter

Rain Oncology Inc. Watch